Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Managing Diabetes Symptoms is Possible with the Right Tools

A recent study from The Centers for Disease Control and Prevention found that 30.3 million Americans have diabetes, while another 84.1 million have prediabetes (which will lead to type 2 diabetes if left untreated).1 Fortunately, with the help of early intervention tools and healthy lifestyle changes, those diagnosed can carry out relatively normal lives and help…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

A recent study from The Centers for Disease Control and Prevention found that 30.3 million Americans have diabetes, while another 84.1 million have prediabetes (which will lead to type 2 diabetes if left untreated).1 Fortunately, with the help of early intervention tools and healthy lifestyle changes, those diagnosed can carry out relatively normal lives and help prevent serious complications, such as vision loss, nerve damage, and painful foot and heel issues from occurring.2 Under the supervision of your physician, you can create a self-care plan which may include:

  1. Measurement: Regularly monitoring blood sugar to ensure levels are within the target range is an important part of managing your diabetes.3
  2. Clinical assessment tools for early detection: AliMed’s monofilaments are one of the most effective testing tools for early detection of sensory loss or neuropathy in diabetic patients and are disposable for single-patient-use and infection control. The Diabetic Neuropathy Device™ is a handheld digital diagnostic tool that allows medical professionals to detect and measure peripheral neuropathy and identify the risks for complications in a three-minute comprehensive foot exam. Baseline® tuning forks enable medical professionals to evaluate hearing and vibratory sensation to assess any hearing loss.
  3. Exercise and weight management: Knowing what type of food and what combinations of foods you can eat, combined with physical activity, is another important part of properly managing your diabetes. Understanding how diet and exercise affect your blood sugar levels is key to maintaining your levels.4
  4. Proper wound care: Wounds heal faster if they are kept warm and moist.5Dressings should be changed quickly to avoid exposing a wound to the open air which can drop its temperature and may slow healing. Wound dressings such as ALGIDEX™ Ag Silver Alginate help create and maintain an optimal moist environment and provide both immediate and sustained antimicrobial protection.
  5. Heel protection and foot care: Foot issues, including sores that don’t heal and ulcers, are a common complication of diabetic neuropathy.6 To help prevent sores from developing keep feet clean and dry and wear cushioned shoes that fit well. Specialty socks and inserts help reduce friction, abrasion, and shear forces. They also help prevent callus formation and improve circulation.
  6. Eye care: Vision loss due to diabetic retinopathy is sometimes irreversible; however, early detection and treatment can reduce the risk of blindness by 95%. People with diabetes or at risk of developing the disease should get a comprehensive dilated eye exam at least once a year. People with diabetic retinopathy may need eye exams more frequently.7

The most important step a diabetic patient can take is to see his or her doctor on a regular basis. Early diagnosis and treatment of any health condition provide the best chance for controlling and preventing future complications. To learn more about AliMed and our products to help manage diabetes, click here.

Read more at alimed.com

RESOURCES

  1. https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
  2. https://www.webmd.com/diabetes/blood-sugar-complications#1
  3. http://www.diabetes.org/diabetes-basics/symptoms
  4. http://www.diabetes.org/diabetes-basics/symptoms
  5. https://www.apma.org/Patients/FootHealth.cfm?ItemNumber=981
  6. https://www.apma.org/Patients/FootHealth.cfm?ItemNumber=981
  7. https://nei.nih.gov/health/diabetic/retinopathy

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512